Trial intelligence / Profile preview

Pregabalin in Central Post-Stroke Pain

NCT00313820Phase 4Completed

Sponsor
Viatris
Start
Aug 2006
Primary completion
Sep 2008
Modality
Small Molecules
Countries
11
01

Overview

Phase 4, randomised, double-blind trial in central poststroke pain (CPSP) comparing Pregabalin with Placebo (2 arms). Primary endpoint: Mean Pain Score at Endpoint as Measured by Daily Pain Rating Scale at 12 weeks. Started Aug 2006; status: completed.

02

Drugs

pregabalin
03

Conditions

central poststroke pain (CPSP)

Beyond the preview

Go deeper on NCT00313820.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00313820.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call